NSBB in Decompensated Cirrhosis: Balancing Benefits and Risks in Ascites Management

March 1, 2024

This activity is designed to educate the audience and bring awareness towards the benefits and risks of non-selective beta-blockers in patients with decompensated cirrhosis and ascites. The participants will be informed of emerging literature and the key results of these important studies that may impact which non-selective beta-blocker should be initiated in practice, if at all, along with critical safety considerations. With this analysis, the participants will discuss of differing viewpoints of NSBBs in these patients, while reviewing the key points of this analysis.

Target Audience

  • Pharmacists
  • Pharmacy Technicians
  • Other Healthcare Professionals

Learning Objectives

Pharmacists learning objectives:

At the conclusion of this activity, pharmacists should be able to:

  1. Review the pathophysiology, etiology, and clinical manifestations of decompensated cirrhosis, particularly ascites and refractory ascites.
  2. Analyze the role of non-selective beta blockers as a therapeutic option in patients with established decompensated cirrhosis.
  3. Evaluate the current literature on the efficacy and safety of non-selective beta blockers in the management of decompensated cirrhosis with ascites.
  4. Discuss the potential adverse effects and risks associated with using non-selective beta-blockers in decompensated cirrhosis.


Pharmacy technician learning objectives

At the conclusion of this activity, pharmacy technicians should be able to:

  1. Recognize the potential consequences and side effects of non-selective beta-blockers in the context of decompensated cirrhosis.

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
Course expires: 
Event starts: 
03/01/2024 - 1:00pm CST
Event ends: 
03/01/2024 - 2:00pm CST
Christiana Hospital
4755 Ogletown Stanton
Ammons Auditorium
Newark, DE
United States


Planning Committee

Priya Bhimani, PharmD 

Sumit Gandotra, PharmD



Umber Muhammad-Olstad, PharmD 
Pharmacy Resident



As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team


Designation Statement(s)


Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for Pharmacists.
Universal Activity Number:JA0006103-9999-24-021-L01-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacy technicians.
Universal Activity Number:JA0006103-9999-24-021-L01-T
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation.  Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.



Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.


If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login in order to proceed with the credit claim process.
Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.